NIKKEI 225
38,662.64 -192.73 (-0.50%) HANG SENG
18,542.05 -279.11 (-1.48%) CRUDE OIL
80.13 +0.30 (+0.38%) GOLD FUTURES
2,358.70 +2.20 (+0.09%) DOW
38,852.86 -216.74 (-0.55%) Bitcoin GBP
53,821.91 +654.28 (+1.23%)
Rigel Pharmaceuticals, Inc. (RIGL)
After hours:
| Previous close | 0.9075 |
| Open | 0.9100 |
| Bid | 0.8922 x 100 |
| Ask | 0.9396 x 200 |
| Day's range | 0.9075 - 0.9500 |
| 52-week range | 0.7100 - 1.7700 |
| Volume | |
| Avg. volume | 1,530,601 |
| Market cap | 163.373M |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced upcoming presentations from their commercial and clinical-stage hematology and oncology portfolio at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) 2024 Hybrid Congress. The ASCO Annual Meeting is being held online and in person in Chicago, Illinois from May 31 to June 4, 2024. The EHA2024 Congress is being held online and in person in Madrid, Spain from June 13 to June 16,
- PR Newswire
Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the first quarter ended March 31, 2024, including sales of TAVALISSE® (fostamatinib disodium hexahydrate) tablets for the treatment of adults with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment and sales of REZLIDHIA® (olutasidenib) capsules for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitr
- PR Newswire
Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2024 financial results after market close on Tuesday, May 7, 2024. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.
